PubMed

Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial.

Bovill EG, Terrin ML, Stump DC, Berke AD, Frederick M, Collen D, Feit F, Gore JM, Hillis LD, Lambrew CT, et al.

Ann Intern Med. 1991 Aug 15;115(4):256-65.PMID: 1906692 [PubMed - indexed for MEDLINE]Related articles

Hemorrhagic events during therapy with recombinant tissue plasminogen activator, heparin, and aspirin for unstable angina (Thrombolysis in Myocardial Ischemia, phase IIIB trial).

Bovill EG, Tracy RP, Knatterud GL, Stone PH, Nasmith J, Gore JM, Thompson BW, Tofler GH, Kleiman NS, Cannon C, Braunwald E.

Am J Cardiol. 1997 Feb 15;79(4):391-6.PMID: 9052337 [PubMed - indexed for MEDLINE]Related articles

Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial. The TIMI Study Group.

[No authors listed]

N Engl J Med. 1989 Mar 9;320(10):618-27.PMID: 2563896 [PubMed - indexed for MEDLINE]Related articles

Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase.

Rao AK, Pratt C, Berke A, Jaffe A, Ockene I, Schreiber TL, Bell WR, Knatterud G, Robertson TL, Terrin ML.

J Am Coll Cardiol. 1988 Jan;11(1):1-11.PMID: 3121710 [PubMed - indexed for MEDLINE]Related articles

Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study.

Roberts R, Rogers WJ, Mueller HS, Lambrew CT, Diver DJ, Smith HC, Willerson JT, Knatterud GL, Forman S, Passamani E, et al.

Circulation. 1991 Feb;83(2):422-37.PMID: 1671346 [PubMed - indexed for MEDLINE]Related articles

Selective versus routine predischarge coronary arteriography after therapy with recombinant tissue-type plasminogen activator, heparin and aspirin for acute myocardial infarction. TIMI II Investigators.

Rogers WJ, Babb JD, Baim DS, Chesebro JH, Gore JM, Roberts R, Williams DO, Frederick M, Passamani ER, Braunwald E.

J Am Coll Cardiol. 1991 Apr;17(5):1007-16.PMID: 1901071 [PubMed - indexed for MEDLINE]Related articles

A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trial.

Cannon CP, McCabe CH, Henry TD, Schweiger MJ, Gibson RS, Mueller HS, Becker RC, Kleiman NS, Haugland JM, Anderson JL, et al.

J Am Coll Cardiol. 1994 Apr;23(5):993-1003.PMID: 8144799 [PubMed - indexed for MEDLINE]Related articles

Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction: the Thrombolysis in Myocardial Infarction (TIMI) II Pilot and Randomized Clinical Trial combined experience.

Sloan MA, Price TR, Petito CK, Randall AM, Solomon RE, Terrin ML, Gore J, Collen D, Kleiman N, Feit F, et al.

Neurology. 1995 Apr;45(4):649-58.PMID: 7723950 [PubMed - indexed for MEDLINE]Related articles

Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial.

Cannon CP, McCabe CH, Diver DJ, Herson S, Greene RM, Shah PK, Sequeira RF, Leya F, Kirshenbaum JM, Magorien RD, et al.

J Am Coll Cardiol. 1994 Dec;24(7):1602-10.PMID: 7963104 [PubMed - indexed for MEDLINE]Related articles

A comparison between heparin and low-dose aspirin as adjunctive therapy with tissue plasminogen activator for acute myocardial infarction. Heparin-Aspirin Reperfusion Trial (HART) Investigators.

Hsia J, Hamilton WP, Kleiman N, Roberts R, Chaitman BR, Ross AM.

N Engl J Med. 1990 Nov 22;323(21):1433-7.PMID: 2122251 [PubMed - indexed for MEDLINE]Related articles

Invasive versus conservative strategy after thrombolytic therapy for acute myocardial infarction in patients with antecedent angina. A report from Thrombolysis in Myocardial Infarction Phase II (TIMI II).

Ruocco NA Jr, Bergelson BA, Jacobs AK, Frederick MM, Faxon DP, Ryan TJ.

J Am Coll Cardiol. 1992 Dec;20(7):1445-51.PMID: 1452916 [PubMed - indexed for MEDLINE]Related articles

One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction.

Anderson HV, Cannon CP, Stone PH, Williams DO, McCabe CH, Knatterud GL, Thompson B, Willerson JT, Braunwald E.

J Am Coll Cardiol. 1995 Dec;26(7):1643-50. Erratum in: J Am Coll Cardiol 2000 Jan;35(1):263. PMID: 7594098 [PubMed - indexed for MEDLINE]Related articles

Intracranial hemorrhage after coronary thrombolysis with tissue plasminogen activator.

Kase CS, Pessin MS, Zivin JA, del Zoppo GJ, Furlan AJ, Buckley JW, Snipes RG, LittleJohn JK.

Am J Med. 1992 Apr;92(4):384-90.PMID: 1558085 [PubMed - indexed for MEDLINE]Related articles

Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator. Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II-A trial.

Rogers WJ, Baim DS, Gore JM, Brown BG, Roberts R, Williams DO, Chesebro JH, Babb JD, Sheehan FH, Wackers FJ, et al.

Circulation. 1990 May;81(5):1457-76.PMID: 2110033 [PubMed - indexed for MEDLINE]Related articles

Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical trial.

Gore JM, Sloan M, Price TR, Randall AM, Bovill E, Collen D, Forman S, Knatterud GL, Sopko G, Terrin ML.

Circulation. 1991 Feb;83(2):448-59.PMID: 1899364 [PubMed - indexed for MEDLINE]Related articles

Evaluation of combination thrombolytic therapy and timing of cardiac catheterization in acute myocardial infarction. Results of thrombolysis and angioplasty in myocardial infarction--phase 5 randomized trial. TAMI Study Group.

Califf RM, Topol EJ, Stack RS, Ellis SG, George BS, Kereiakes DJ, Samaha JK, Worley SJ, Anderson JL, Harrelson-Woodlief L, et al.

Circulation. 1991 May;83(5):1543-56.PMID: 1902405 [PubMed - indexed for MEDLINE]Related articles

Patency trials with reteplase (r-PA): what do they tell us?

Bode C, Nordt TK, Peter K, Smalling RW, Runge MS, Kübler W.

Am J Cardiol. 1996 Dec 19;78(12A):16-9. Review.PMID: 8990406 [PubMed - indexed for MEDLINE]Related articles

A randomized trial of recombinant staphylokinase versus alteplase for coronary artery patency in acute myocardial infarction. The STAR Trial Group.

Vanderschueren S, Barrios L, Kerdsinchai P, Van den Heuvel P, Hermans L, Vrolix M, De Man F, Benit E, Muyldermans L, Collen D, et al.

Circulation. 1995 Oct 15;92(8):2044-9.PMID: 7554180 [PubMed - indexed for MEDLINE]Related articlesFree article

Thrombolysis in Myocardial Infarction (TIMI) phase II trial: outcome comparison of a "conservative strategy" in community versus tertiary hospitals. The TIMI Research Group.

Feit F, Mueller HS, Braunwald E, Ross R, Hodges M, Herman MV, Knatterud GL.

J Am Coll Cardiol. 1990 Dec;16(7):1529-34.PMID: 2123901 [PubMed - indexed for MEDLINE]Related articles

Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

Chesebro JH, Knatterud G, Roberts R, Borer J, Cohen LS, Dalen J, Dodge HT, Francis CK, Hillis D, Ludbrook P, et al.

Circulation. 1987 Jul;76(1):142-54.PMID: 3109764 [PubMed - indexed for MEDLINE]Related articles